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Summary 
Murine bone marrow-derived cells, dependent on interleukin 3 (I1.3) for their growth in culture, 
undergo programmed cell, or apoptosis, upon cytokine withdrawal. Here it is reported that a 
variety of DNA damaging agents cause a more rapid onset of apoptosis in a factor-dependent 
cell line, BAF3, deprived of I1.-3. In contrast, when cultured in the presence of I1.3, or other 
growth promoting factors,  BAF3 cells are highly resistant  to X-irradiation and the cytotoxic 
drugs etoposide and cisplatin. Overexpression of the bcl2 gene product also protects BAF3 cells 
from DNA damage. The presence of I1-3 is not required during the initial events of DNA damage 
or its repair.  In the absence of I1-3, cells still complete the repair of DNA breaks  within 15 
min, and continue to cycle for 5 h. At this time, I1-3 is necessary to prevent the accelerated 
onset of DNA cleavage from a G2 arrest  point. 
T 
he development of haematopoietic cells can be controlled 
by regulating the rate of programmed cell death, or apop- 
toffs,  as well as the rate of cell proliferation. For example, 
those thymocytes that are triggered by antigen within the 
thymus die by apoptosis (1), which provides a mechanism 
for the elimination of self-reactive T lymphocytes. In con- 
trast, B lymphocytes from the germinal centers of lymph nodes 
apoptose if they are not antigen triggered (2), allowing the 
selection of cells producing high affinity antibodies. Expan- 
sion and maturation of the immature progenitor cells of bone 
marrow also appear to be controlled by a balance between 
proliferation and apoptosis.  The proliferation of such cells 
is stimulated by cytokines, including I1.3 and GM-CSF, which 
act on the earliest precursor cells (3, 4). Upon withdrawal 
of II.-3 or GM-CSF from progenitor cell lines (5, 6) or pri- 
mary I1.3-dependent cells from bone marrow (6), a program 
of events typical of apoptosis is observed, which includes the 
digestion of cellular  chromatin to oligonucleosome-length 
fragments by an endogenous nuclease. This provides a model 
for the regulation of haematopoiesis in mouse bone marrow 
where the least mature progenitor cells are not cycling (7), 
but after the stimulation of haematopoiesis, activated  pro- 
genitor cells proliferating in response to cytokines could be 
induced to apoptose when cytokines are no longer available, 
rapidly terminating their expansion. 
The mechanism by which cytokines such as II-3 protect 
cytokine-dependent cells from the onset of apoptosis remains 
unclear. The initial interaction of II.-3 with its receptor stimu- 
lates rapid events such as the tyrosine phosphorylation of cel- 
lular proteins (8). However, such signals decay rapidly upon 
I1.3 removal (8), whereas the initiation of DNA deavage does 
not occur until 6 h after I1.3 deprivation (6). The protective 
action of I1.3  can be  mimicked either by  other  growth 
promoting factors that interact with homologous receptors, 
such as GM-CSF (5) and I1.4 (9), or by the overexpression 
of the product of the bcl2 oncogene (10, 11). However, un- 
like cytokines, bcl2 inhibits the onset of apoptosis but does 
not cause cells to proliferate. 
In addition to its role in the control of haematopoietic cell 
development and immune repertoire selection, the induction 
of apoptosis is involved in the mechanism of killing of tumor 
cells by a number of therapeutic regimes. A variety of agents 
used for some time in human tumor therapies, such as antag- 
onists of steroid hormones (12), glucocorticoids (13), DNA 
damaging drugs (14, 15), or radiation (16) have recently been 
demonstrated to kill cells by inducing apoptosis. Again, the 
mechanism by which initial DNA damage leads to subse- 
quent cleavage of DNA remains unclear. Among normal cells, 
those of the haematopoietic system are the most sensitive when 
exposed in vivo to DNA damaging agents. Because I1.3 will 
protect bone marrow-derived haemopoietic cells from apop- 
tosis, we investigated whether cytokines will protect against 
apoptosis induced by DNA damaging agents. We show that 
I1.-3, other growth promoting factors, and the bcl2 protein 
inhibit the rapid apoptosis induced by DNA damaging agents 
in murine bone marrow-derived I1.3-dependent cells. The 
extent of DNA damage and its repair were not affected by 
II.-3. The cytokine acted 6 h after these initial events to allow 
cells to pass a restriction point at which DNA damage is 
detected. 
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Cell Culture and Reagents.  BAF3  cells (17; obtained from Dr. 
Konald Palacios, Basel Institute for Immunology, Basel, Switzer- 
land) were maintained  in DMEM containing 10% fetal  bovine  serum 
(FBS)  1 and 5% WEHI 3B cell-conditioned medium which was 
used throughout as a source of IL-3, at a density of 5  x  104-5 
x  10  s cells/ml. Primary IL-3-dependent cultures of murine bone 
marrow ceUs were prepared as previously  described (6). They were 
characterized largely  as mast cells  by the release of  ~-glucosaminidase 
upon calcium ionophore stimulation. To remove Ib3, calls were 
washed twice in DMEM/10%  FBS. Cell viability and viable cell 
density were determined by counting cells able to exchde trypan 
blue on a haemocytometer. Duplicate samples of at least 50 ceLls 
were analyzed. Murine IL-4 was obtained from Genzyme Corp. 
(Boston, MA), insulin-like growth factor (IGF-1) from Bachem 
(Bubbendorf,  Switzerland),  A23187 from  Calbiochem  Corp. 
(Boston,  MA),  etoposide from  Bristol-Myers (Slough, UK), 
and  cisplatin from  David  Bull Laboratories (Warwick,  UK). 
X-irradiation was performed using a Pantac  x-ray machine (Chester 
Beatty Laboratories), with an output of 24 0 keV at a dose rate 
of 250-300 rad/min. 
DNA Fragmentation.  107 cells were lysed in 0.75 ml 10 mM 
Tris (pH 8.0), 150 mM NaC1, 0.1 mM EDTA, 1% SDS, and in- 
cubated for 15 h with 200 #g/ml proteinase K at 37~  After ex- 
traction  with 50%  phenol/50%  chloroform,  total  DNA  was 
precipitated by addition of 1/10 vol 3 M NaAcetate (pH 5.0) and 
2.5 vol ethanol and incubation for 15 h at -20~  The DNA pellet 
was resuspended in 50 #1 10 mM Tris (pH 8.0), 0.1 mM EDTA, 
and the nucleic acid concentration determined by measurement of 
ODz60. 15 #g of nucleic acid was incubated for 1 h at 37~  with 
10 U/ml DNAse-fi~ RNAse, then electrophoresed  on a 1% agarose 
gel in the presence of ethidium bromide. A 1-kb DNA ladder size 
marker (Gibco-BRL, Gaithersburg, MD) was included in the last 
lane of each gel. 
Detection of Single-stranded DNA Breaks.  The differential rates 
of elution of test sample DNA and an internal standard DNA, at 
alkaline pH, were used to detect the presence of single-stranded 
DNA breaks in the test samples. DNA was labeled by culture of 
test cells for 15 h with 0.5 #Ci/ml [uC]thymidine (Amersham In- 
ternational, Amersham, Bucks, UK) and culture of standard cells 
with 0.5 #Ci/ml [3H]thymidine (Amersham International). Im- 
mediately before irradiation,  test  cells were  washed twice  in 
DMEM/10% FBS, suspended  in DMEM/10% FBS containing 50 
mM Hepes pH 7.0, placed on ice, and irradiated. A nonirradiated 
and an irradiated control test cell sample were maintained on ice 
and other test samples were incubated at 37~  with Ib3 if indi- 
cated, for the time shown. An equivalent number (10  ~) of each 
test sample and standard cells were then admixed on ice, pelleted 
at 4~  resuspended in PBS, and loaded onto polycarbonate filters 
at 4~  The rate ofelution of test and standard  DNA in each sample 
by 2% tetrapropylammoniumhydroxide  (pH 12.1) was then mea- 
sured, after cell lysis and protease digestion,  as previously de- 
scribed (18). 
Cell Cycle Analysis.  5  x  106 cells were pelleted, resuspended 
in 0.2 ml PBS, and fixed by the addition of 2 ml of ice-cold 75% 
ethanol/25% PBS. Fixed  cells were pelleted, vigorously  resuspended 
in PBS, and incubated for 30 min at 37~  with 100 #g/ml RNase 
and 40 #g/ml propidium iodide. The fluorescence  of the stained 
1  Abbreviations used in this paper: FBS, fetal  bovine scum; IGF-1, insulin- 
like growth factor 1. 
cells was analyzed using a FACScan  |  (Becton Dickinson & Co., 
Mountain View, CA). 
Generation ofbd2-expressing Cells.  A 1.9-kb human bc12 eDNA 
fragment was inserted in the EcoRI restriction site of the retroviral 
pM5Gneo (from C. Stocking, Heinrich-Petter Institut, Hamburg, 
Germany). After transfection of this vector into the packaging cell 
line ~2 (19) and selection in G418 a producer cell clone, which 
transferred G418, resistance  to National Institutes of Health (NIH) 
3T3 cells at a frequency of 104 resistant colonies/ml producer cell 
supernatant, was isolated. BAF3 cells were infected by cocultiva- 
tion with this producer cell clone, and a cell population which was 
100% positive  for the expression of  human bcl2, assessed  by fluores- 
cence activated  cell analysis  using an anti-human bcl2 antibody (20), 
was used for further experiments. 
Results 
IL3 Inhibits Apoptosis Induced by DNA Damaging  Agents 
in a Murine Bone Marrow-derived Cell Line and in Primary Cul- 
tures of Murine  Bone Marry.  The murine bone marrow- 
derived cell line BAF3 has been shown to undergo apoptosis, 
characterized by an initial deavage of cellular chromatin and 
a subsequent loss of plasma membrane integrity, upon with- 
drawal  of Ib3  (6).  Fig.  1 A  demonstrates  that  such  IL- 
3-deprived BAF3 cells began to lose viability 13 h after factor 
removal, and death was asynchronous within the cell popu- 
lation and complete only after 28 h. When BAF3 calls were 
exposed to X-irradiation (400 tad) immediately after II,3 with- 
drawal, this loss of  viability was more rapid and synchronous, 
being first observed after 8 h and essentially complete after 
18 h  (Fig.  1 A).  In the presence  of II--3, BAF3 cells were 
completely resistant to this dose of radiation for 36 h (Fig. 
1 A). Some loss of cell viability was observed  over the fol- 
lowing 36 h, and is shown in Fig. 1 C. During these first 
72  h  after  X-irradiation,  the  viable  cells  showed  little 
[3H]thymidine incorporation (data not shown) and failed to 
increase in number (Fig. 1 C). However, exponential growth 
was observed after this initial lag period (Fig. 1 C). The viable 
calls in the culture were therefore able to divide normally. 
Indeed, 72 h after X-irradiation, such cells showed a cloning 
efficiency assessed  by limiting dilution of 83%, compared with 
87%  of control cells. We have previously shown that pri- 
mary murine bone marrow cells, cultured in the presence of 
II,3, also apoptose upon cytokine removal (6). Such primary 
IL-3-dependent cultures, which were largely mast cells, also 
lost viability rapidly upon exposure to 400 tad of X-irradiation 
and could be protected from death by the presence  of Ib3 
(Fig.  1 D). 
The main effect of X-irradiation at a dose of 400 rad is 
the induction of single-stranded DNA breaks (18). There- 
fore, to investigate whether DNA damage was responsible 
for the rapid induction of death in BAF3 cells, other agents 
known to induce DNA damage were used to treat BAF3 ceUs 
deprived of Ib3.  Fig.  1 B  demonstrates that etoposide,  a 
topisomerase II inhibitor that also induces both single-stranded 
DNA and double-stranded breaks (21), and cisplatin, which 
causes DNA strand crosslinks  (22), both induced cell death 
with similar kinetics to that observed after X-irradiation.  ID3 
inhibited the action of these agents for the initial 24 h  of 
culture (Fig.  1 B).  At this time, removal of the drugs by 
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The induction  of apoptosis by DNA damaging agents and its inhibition  by IL-3. (A) BAF3 cells were washed to remove Ib3, exposed 
to 400 tad X-irradiation as indicated, then incubated,  in the absence or presence of 1I.-3 as indicated,  for the time shown. Cell viability  was then deter- 
mined. (13) BAF3 cells were incubated  for the time shown  with II.,3, 1/zg/ml etoposide  and 4/~g/ml cisplatin as indicated, after  which cell viability 
was determined. (C) 2 x  10  s BAF3 cells were exposed to 400 tad X-irradiation, then incubated in the presence of IL-3 for the time shown, when 
the number and percentage of viable cells was determined.  Cells were maintained  at a density  of <5  x  10  s cells/ml. (D) Primary  cultures of Ib3-de- 
pendent mast cells from murine bone marrow were treated as in A. 
washing resulted in the recovery of cells that remained viable 
during subsequent culture. 
The early loss of  viability, observed after treatment of BAF3 
cells with various DNA damaging agents, suggested that these 
agents might trigger the apoptotic pathway more rapidly than 
II.-3 removal alone. To investigate this, the time of initiation 
of DNA deavage in X-irradiated, and etoposide- or cisplatin- 
treated  BAF3  cells  was  observed.  Fig.  2  A  shows  that 
oligonucleosome-length DNA fragments, characteristic of 
cleavage of cellular chromatin by an endogenous nuclease (13), 
could be detected 4 h after treatment of IL-3-deprived cells 
with these agents. In control cultures deprived of II.-3, such 
fragmentation was not observed until 8 h (reference 6 and 
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Fig. 2 A). DNA cleavage was not detected in cultures treated 
with DNA damaging agents in the presence  of II.-3 (Fig. 
2 A). Thus, initial endogenous nuclease digestion of chro- 
matin precedes initial loss of cell viability by 4-5 h in both 
DNA-damaged and control Ib3-deprived cells. Unlike this 
fixed time period after which cell death occurs once cleavage 
is initiated, it is clear that the time of onset of cleavage can 
be greatly shortened by DNA damaging agents. 
The ability of IL3 to protect BAF3 cells from X-irradiation 
or cytotoxic drugs could be demonstrated at very high doses 
of the DNA damaging agents. In the absence of IL-3,  100 
rad of X-irradiation, 0.5 ~g/ml cisphtin or 0.05 #g/ml etopo- 
side were sufficient to induce the rapid onset of apoptosis Figure 2.  Effect of DNA damaging agents on DNA fragmentation. (Uppert, anel  ) BAF3 cells were X-irradiated (A and E), treated with 1/~g/ml 
etoposide (B and F) or 1/tg/ml cisplatin (C and G), then incubated in the absence (A-C) or presence  (E-G) of I1.,3 for 2 h  (lanes I), 4 h  (lanes 
2), 6 h  (lanes 3), 8 h (lanes 4),  12 h  (lanes 5), and 23 h  (lanes 6). (D) DNA prepared from cells at the same time points, after II.-3 removal in the 
absence of any DNA damaging treatment. Fragmentation of cellular DNA was then analyzed.  (Lower  panel) BAF3 cells were incubated for 15 h in 
the presence of I1.,3, either after X-irradiation: (A) lanes I. 200 tad; 2. 400 rad; 3. 800 tad; 4.  1,600 tad; 5. 3,200 tad); or in the presence of etoposide: 
(B) lanes I. 0.04/~g/ml;  2. 0.1/zg/ml; 3. 0.4/~g/ml;  4.  1/~g/ml; 5. 4/~g/ml); with no addition (C) or in the presence of cisplatin: (D) Lanes l. 
1 ttg/ml; 2.  2 #g/ml; 3.  4/~g/ml; 4.  8 #g/ml;  and 5.  16/~g/ml).  Fragmentation of cellular DNA was  then analyzed. 
(data not shown). In the presence of IL-3, the calls were resis- 
tant to 1,600 tad of X-irradiation.  8 #g/ml cisplatin, or 0.05 
/zg/ml 1/zg/ml etoposide (Fig. 2 B) which represent higher 
levels than are normally tolerated by eucaryotic cells (14, 21). 
Other Growth.promoting  Factors  and the bcl2 0ncogene  Product 
also Protect Cells  from X-irradiation.  Protection of these cells 
was not confined to IL-3. We have previously demonstrated 
that the growth-promoting factors IGF-1 and II.-4 can pro- 
tect BAF3 cells from apoptosis when II.,3 is removed (6, 23). 
Fig. 3 demonstrates that either IGF-1 or IL-4 was effective 
in protecting the cells  from X-irradiation. We have also demon- 
strated that the calcium ionophore A23187 can inhibit onset 
of apoptosis in the absence of IL,3 (6). Unlike IGF-1 or II.,4, 
A23187 does not stimulate proliferation of  BAF3 ceils. When 
added alone, the ionophore maintains ceUs  viable but not cy- 
cling, and when added in the presence of IL-3, it arrests their 
cell cycle (6). The observation that A23187 alone or in com- 
bination with 11,3 could protect BAF3 cells  from X-irradiation 
(Fig. 3 A) therefore suggested that cells do not need to cycle 
to recover from its effect. Because of the difficuhy of main- 
taining cells for more than 48 h with calcium ionophores, 
this conclusion was best demonstrated when the effect  of  over- 
expression of  the bcl2 protein on the sensitivity of  BAF3 cells 
to radiation  was observed. Fig. 3 B shows the behavior of 
a population  of BAF3 cells, infected  with a recombinant 
retrovirus encoding human bcl2 protein, when deprived of 
Ib3 and exposed to X-irradiation. The cells expressing human 
bc12 protein showed a normal cell cycle distribution when 
grown in IL-3 (Fig. 3 B, pand a) but arrested with diploid 
DNA content 48 h after II,3 was removed (Fig. 3 B, panel 
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Figure 3.  Inhibition  of the effect of X-irradiation by a variety of agents. 
(.4) BAF3 cells were exposed to 400 rad X-irradiation,  then incubated for 
15 h with IL-3, IGF-1 (1/~g/ml), II.-4 (10 U/ml), and A23187 (1/~M) 
as indicated, after which cell viability was determined. (/3) BAF3 cells over- 
expressing human bd2 were deprived of IL-3 for 15 h. Cell cycle analysis 
at this point (b) shows that the cells are arrested in the G1 phase of the 
cell cycle, compared with the same cells cultured in Ib3 (a). (C) The ar- 
rested cells were exposed to 400 tad of X-irradiation,  and the viability 
of irradiated and control arrested human bcl2 cells, and irradiated and con- 
trol parental BAF3 cells, was determined  at the times indicated. 
b). Such arrested cells lost viability after "~100 h total IL-3 
deprivation (Fig. 3 C), and their rate of death was not ac- 
celerated by X-irradiation  (Fig. 3 C). 
II~3 Does Not Affect the Extent of  DNA Damage or the Rate 
of Its Repair.  To investigate the mechanism by which IL-3 
protected BAF3 cells from X-irradiation,  the extent of repair 
of DNA damage was measured in cells X-irradiated at 4~ 
in the absence of I1-3, then incubated in the absence or pres- 
ence of IL3 at 37~  Single-stranded DNA breaks after a 
dose of 400 tad were detected by alkaline filter elution (18). 
No double-stranded DNA breaks could be detected by neu- 
tral filter elution (24). Fig. 4 A demonstrates that the initial 
single-stranded  DNA breaks were undetectable  after a 1-h 
incubation in either the absence or presence of I1"3. This sug- 
gested that DNA damage did not lead directly to the onset 
of  DNA cleavage in cells deprived of I1"3. However, the sen- 
sitivity of this measurement of single-stranded DNA breaks 
did not exclude the possibility that a small number of breaks 
remained unrepaired in the cells deprived of I1"3. The rate 
of DNA repair was therefore measured in cells deprived of 
I1-3 for 6 h. After 5 rain, the extent of  DNA repair was iden- 
tical in 11-3-deprived (Fig. 4 C) and control cells (Fig. 4 B) 
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and no breaks could be detected after 15' in either culture 
(data not shown). Thus, as the rate of repair was not im- 
paired in cells deprived of II-3 for 6 h, a failure to repair a 
small number of breaks seemed unlikely to be responsible 
for the damage sensitivity  of I1"3-deprived cells. 
11,3 Allows Cells To Pass a G2 Restriction Point at which DNA 
Repair Is Monitored.  Because I1"3 did not affect the initial 
repair of DNA damage,  it was then determined at which 
point during induction of the apoptotic process the presence 
of I1"3 was necessary. Fig. 5 shows that I1"3 could be re- 
moved from control BAF3 cells for 9 h, then readded with 
no  subsequent  loss  in  cell viability.  Further experiments 
demonstrated that this period of I1"3 deprivation  could be 
extended to 12 h (data not shown). X-irradiated cells could 
be deprived of I1-3 for the first 2 h after irradiation with no 
loss in viability upon I1-3 readdition. Even at 6 h after irradi- 
ation,  70%  of the cells could be rescued by I1-3 (Fig. 5). 
These data demonstrate that the first irreversible event in the 
onset of apoptosis occurred close to the time of initiation 
of DNA cleavage in both control and X-irradiated  ceils. 
As the point at which II.,3 protected cells  from X-irradiation 
was several hours after the initial damage and repair, the cy- 100- 
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Figure 4.  Measurement of tingle-stranded DNA breaks and their re- 
pair. (A) Comparative rates of elution of test (14C-labeled) and internal 
standard (~H-labeled)  DNA. Test samples were prepared from BAF3 cells 
that  were washed  to remove I1,3,  then analyzed (D),  given 400 rad 
X-irradiation, and analyzed without further treatment (O), or irradiated 
and then incubated for 1 h at 37~  in the absence (&) or presence (m) 
of 11,3. (B) Test samples were prepared from control BAF3 cells (V1), cells 
given 400 tad X-irradiation  in the presence of II.,3 (O), and irradiated 
cells subsequently incubated for 5' at 37~  in the presence of I1,3 (I). 
(C) Test samples were prepared from BAF3 cells deprived of IL-3 for 6 h 
([3), these cells were given 400 tad X-irradiation  in the absence of 11,3 
(0), and these irradiated cells subsequently incubated for 5' at 37~  in 
the absence of I1,3 (I). 
cling of the cells during this period in the absence  or pres- 
ence of IL-3 was observed by cytofluorimetry of propidium 
iodide-stained cells.  The presence of a subdiploid DNA con- 
tent population,  with light  scatter  characteristics  identical 
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Figure 5.  Determination of the time at which I1,3 is required to pre- 
vent cell death. BAF3 cells were washed to remove I1,3 and irradiated with 
400 tad X-rays as indicated. They were then incubated at 37~  for the 
time shown in the absence of I1,3. I1,3 was then readded and cell viability 
was determined  24 h after the initial I1,3 deprivation. 
to the rest of the cells, can be used as a measure of the number 
of cells undergoing  apoptosis (6).  In control cells deprived 
of I1,3,  such a population was <5%  of the total 9 h after 
factor removal.  At this time the cells were still distributed 
throughout  the cell cycle very much as were cells cultured 
in II-3 (Fig. 6). Thus removal of I1,3 did not result in any 
rapid  cessation  of  cell  cycle  progression  in  these  cells. 
X-irradiation of the cells resulted in an accumulation in the 
G2 phase of the cell cycle,  which was similar in the absence 
or presence  of IL-3 (Fig.  6).  This is characteristic  behavior 
of eucaryotic cells exposed to DNA-damaging  agents (25). 
However, in the absence of Ib3, apoptotic cells began to ap- 
pear in the culture after 6 h.  This  appearance of apoptotic 
9h 
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Figure 6.  Cell cycle analysis of X-irradiated cells. The cell cycle distri- 
bution of BAF3 cells cultured in the presence of I1,3 (A), in the absence 
of I1,3 (B), X-irradiated with 400 rad, then cultured in the presence of 
I1,3 (C), or X-irradiated with 400 tad,  then cultured in the absence of 
IIr  (D),  for the time shown, was determined. 
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cell cycle  inhibitors on radiation-induced 
apoptosis. (A) The cell cycle  distribu- 
tion of BAF3 cells exposed  to 400 rad 
X-irradiation, incubated  for t h at 37°C, 
then cultured for a further 5 h in the 
absence  oflb3 (panel I), with 10 #g/ml 
cycloheximide  (panel  2), 5 #g/ml aphi- 
dicholine (panel 3), or 500 ng/ml col- 
cemid (pand 4). (B) DNA fragmenta- 
tion after 6 h of the cells of A. Lane 
I, no addition; lane 2, aphidicholine; 
lane 3, cycloheximide;  and lane 4, col- 
cemid. The concentration of cyclohex- 
imide used  inhibited protein synthesis, 
measured by incorporation of [3sS]me- 
thionine during a 1-h period 5 h after 
irradiation, by 91% and that of  aphidi- 
choline inhibited protein synthesis  by 
40%. In contrast, cycloheximide  in- 
hibited [3H]thymidine incorporation 
during the 6 h after  irradiation by 26% 
and aphidicholine by 96%. 
cells was accompanied by a loss of ceils from the G2 arrest 
point  (Fig.  6 B). 
To investigate whether a checkpoint  associated with G2 
arrest was directly responsible for the onset of apoptosis, we 
used agents that prevented this G2 arrest.  Fig. 7 A  demon- 
strates that both cycloheximide, an inhibitor of protein syn- 
thesis,  and aphidicholine,  which inhibits DNA polymerase 
c~ and therefore blocks DNA replication,  prevented the ac- 
cumulation  of cells in G2 after X-irradiation  in the absence 
of IL-3. Significantly, both of these agents were able to pre- 
vent the rapid onset of DNA deavage observed in control 
cells that  had  accumulated  in G2 (Fig.  7 B),  whereas cob 
cemid, which blocks the cell cycle in mitosis and thus does 
not affect the G2 arrest point, had no effect on the radiation- 
induced  DNA deavage  (Fig.  7 B). 
Discussion 
The data presented here demonstrate  a direct inhibition 
by cytokines of apoptosis triggered by DNA damage.  Var- 
ious cytokines have been shown to be radioprotective in vivo 
(for review see reference 26). They can be classified into those 
that can be given before radiation and afford subsequent pro- 
tection,  such as ILl  (27) and YNF-ol (27),  and those that 
have been shown to be myelorestorative when given after ir- 
radiation.  IL-3 belongs to the latter category (28), and under 
these conditions, presumably acts to stimulate the prolifera- 
tion of residual undamaged progenitor cells. The direct pro- 
tection of BAF3 cells by Ib3, and other growth-promoting 
factors, suggests that bone marrow  progenitor  cells might 
be protected by appropriate cytokines administered  during 
chemo- or radiotherapy of nonhaematopoietic tumors. It also 
implies that differential sensitivity of a variety of tumors to 
DNA damaging  drugs  or radiation  could be explained by 
their production of autocrine growth factors, or overexpres- 
sion of the bd2 protein. 
The presence of Ib3 does not affect the initial extent of 
DNA breaks caused by irradiation,  or their  rate of repair. 
Therefore, the mechanism by which DNA damage leads to 
apoptosis in BAF3 cells deprived of Ib3 involves the detec- 
tion of DNA repair.  The arrest of eucaryotic cells in the G2 
phase of the cell cycle subsequent to DNA damage and re- 
pair is a well-recognized phenomenon (25) and, although the 
molecular basis of this control is not understood, yeast mu- 
tants deficient in this regulation have been isolated (29). The 
death of BAF3 cells  from  such a G2 restriction  point  and 
its inhibition by preventing cells from reaching  the restric- 
tion point, demonstrates that cells are particularly sensitive 
to the onset of apoptosis when arrested there in the absence 
of IL-3. However, it is dear that  arrest in G2 per se is not 
necessary for recovery of BAF3 cells from DNA damage in 
the presence of IL3. Bcl2 overexpressing cells, which remain 
arrested in  G1  in  the  absence of IL-3,  are also resistant  to 
X-irradiation.  Such radio-resistance  has  also been reported 
in thymocytes isolated from transgenic mice overexpressing 
bcl2 (30, 31), and we have also demonstrated that bcl2 over- 
expressing BAF3 cells are resistant to DNA damaging agents 
such as etoposide (Ascaso,  R.,  M.  Collins, J.  Marvel,  and 
A. Lopez-Rivas, manuscript in preparation). Whether main- 
tenance or induction of bcl2 function represents part of the 
mechanism  of action of Ib3 remains  to be investigated.  A 
decrease in  bcl2  mRNA  has  been reported  late  after  Ib3 
removal from a factor-dependent  cell line (10). 
IL-3 removal from either control,  or X-irradiated  BAF3 
cells does not  affect the cycling of the cells.  Furthermore, 
IL-3 is not required  to protect cells from apoptosis until  a 
time point very close to the initiation of DNA cleavage. This 
implies that 11,-3 is not only a growth factor that is required 
to maintain cell proliferation of these factor-dependent cells, 
but  also a survival factor that  prevents the onset of DNA 
cleavage.  The signaling pathway that leads to apoptosis after 
II.-3 removal requires  at least 8 h  for the initiation  of this 
cleavage.  DNA damage  either  induces a different pathway 
or the same pathway with more rapid kinetics,  as cleavage 
in this case starts after 4 h. The ability of II_-3 to rapidly re- 
verse the apoptotic program  when added close to the time 
of nudease cleavage,  argues against  a coordinated and irre- 
versible program of gene expression leading to apoptosis. One 
possibility is that  II~3  acts to maintain  the level of crucial 
1049  Collins  et al. cellular metabolites such as ATP (32).  It is known that the 
presence  of DNA  strand breaks  causes  the  activation of 
poly(ADP-dbose)polymerase, which consumes cellular NAD + 
leading to a fall in ATP (33).  This could explain the more 
rapid onset of apoptosis after DNA damage. To define the 
mechanism of action of IL-3, it is now necessary to identify 
the cellular changes that immediately precede onset of DNA 
cleavage, determine how they lead to an increase in nuclease 
activity, and demonstrate their rapid reversal by Ib3. 
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